TheraRadar

Pharma Intelligence, Simplified

Landscape → Musculoskeletal

Osteoporosis

192 clinical trials

72 active
/
192 total (since 2015)
8
Phase 1 Active
33 total
14
Phase 2 Active
45 total
12
Phase 3 Active
48 total
40
Phase 4 Active
75 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Amgen 2 5 0
Qilu Pharmaceutical Co., Ltd. 2 0 0
Shenzhen Salubris Pharmaceuticals Co., Ltd. 1 2 0
Mabwell (Shanghai) Bioscience Co., Ltd. 1 2 0
Angitia Biopharmaceuticals 1 1 0
Help Therapeutics 1 0 0
Xeolas Pharmaceuticals Limited 1 0 0
Luye Pharma Group Ltd. 1 0 0
Insud Pharma 1 0 0
Radius Health, Inc. 0 5 0
NCT04922333 RECRUITING
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
Wake Forest University Health Sciences n=200
NCT07154719 NOT YET RECRUITING
GLP-1R Actions on Muscle and the Skeleton
Pennington Biomedical Research Center n=50
NCT07062978 RECRUITING
A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
Qilu Pharmaceutical Co., Ltd. n=278
NCT07047131 ACTIVE NOT RECRUITING
Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants
Marco Esposito n=50
NCT05998863 RECRUITING
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
University of Texas Southwestern Medical Center n=56
NCT06898060 NOT YET RECRUITING
To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd. n=282
NCT06804590 RECRUITING
A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis
Mabwell (Shanghai) Bioscience Co., Ltd. n=278
NCT06773923 ENROLLING BY INVITATION
Effectiveness of 3D-printed Patient-specific Resorbable Scaffolds for Maxillary Bone Regeneration
Universidad Austral de Chile n=10
NCT05918029 RECRUITING
Bone in CKD Alkali Response (BICARb Pilot Trial)
Albert Einstein College of Medicine n=103
NCT05602493 ACTIVE NOT RECRUITING
A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction
Xeolas Pharmaceuticals Limited n=60
NCT05853354 ACTIVE NOT RECRUITING
Comparative Efficacy, Safety, PK, and Immunogenicity Study
Luye Pharma Group Ltd. n=392
NCT06242782 NOT YET RECRUITING
Vertical Ridge Augmentation Strategies
University College, London n=148
NCT05405725 COMPLETED
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®
Enzene Biosciences Ltd. n=504
NCT04779216 COMPLETED
Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa
Karen Klahr Miller, MD n=30
NCT03292146 COMPLETED
Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study
Massachusetts General Hospital n=30
NCT05345691 COMPLETED
Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis
Biocon Biologics UK Ltd n=479
NCT07028320 COMPLETED
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Shenzhen Salubris Pharmaceuticals Co., Ltd. n=493
NCT05395091 COMPLETED
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND
Alvotech Swiss AG n=532
NCT06504966 WITHDRAWN
Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®
Xentria, Inc.
NCT05338086 COMPLETED
A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.
mAbxience Research S.L. n=558
NCT06853392 COMPLETED
Socket Preservation Using Dentin Graft Autogenous Dentin Graft With Collagen Sponge on Dental Implant Stability AUTOGENOUS TOOTH GRAFT WITH COLLAGEN SPONGE ON DENTAL IMPLANT STABILITY
Faculty of Dental Medicine for Girls n=16
NCT04934072 COMPLETED
A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis
Fresenius Kabi SwissBioSim GmbH n=553
NCT04591275 COMPLETED
Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .
Shanghai Biomabs Pharmaceutical Co., Ltd. n=278
NCT04664959 COMPLETED
A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis
Samsung Bioepis Co., Ltd. n=457
NCT06780956 COMPLETED
Simplified vs Conventional Drilling Protocol for Implant Placment
Universidad Católica San Antonio de Murcia n=46
NCT06770894 COMPLETED
DPP4-Inhibitors and Bone Metabolism in Diabetes
Azienda Policlinico Umberto I n=132
NCT05067335 COMPLETED
A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis
UCB Biopharma SRL n=327
NCT05087030 COMPLETED
Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis
Gedeon Richter Plc. n=473
NCT03164928 COMPLETED
Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis
Amgen n=24
NCT04757376 COMPLETED
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
Celltrion n=479
NCT03401060 COMPLETED
Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis
Assistance Publique - Hôpitaux de Paris n=24
NCT04729621 COMPLETED
A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis
Teva Pharmaceuticals USA n=332
NCT03930992 COMPLETED
Efficacy of Zoledronic Acid + Colaren vs Zoledronic Acid + Conventional Treatment for Osteoporosis in HIV+ and HIV- Men
University of Guadalajara n=30
NCT05215977 COMPLETED
Efficacy and Safety of MW031 in PMO Subjects
Mabwell (Shanghai) Bioscience Co., Ltd. n=448
NCT03512262 COMPLETED
Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
Radius Health, Inc. n=228
NCT03974100 COMPLETED
Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis
Sandoz n=527
NCT04064411 COMPLETED
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
Radius Health, Inc. n=511
NCT05631600 COMPLETED
Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study
University of Zagreb n=12
NCT03812380 TERMINATED
Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate
University of Texas Southwestern Medical Center n=62
NCT02832648 COMPLETED
Selenium for Musculoskeletal Health
Sheffield Teaching Hospitals NHS Foundation Trust n=123
NCT04169698 COMPLETED
Alendronate Versus Denosumab in Kidney Transplant Patients
Ain Shams University n=90
NCT03710889 COMPLETED
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
Radius Health, Inc. n=23
NCT03432533 COMPLETED
A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
Amgen n=283
NCT03331185 COMPLETED
Changes of Soft and Hard Tissues After Alveolar Ridge Preservation: Freeze-dried Bone Allograft vs. L-PRF Clot
University of Manitoba n=26
NCT03040765 TERMINATED
Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis
Hamad Medical Corporation n=17
NCT02791516 COMPLETED
A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis
Amgen n=67
NCT03178526 COMPLETED
The Effect of Lovastatin Gel in the Treatment of Chronic Periodontitis
Islamic Azad University, Sanandaj n=15
NCT03002428 COMPLETED
A Comparison of PF708 and Forteo in Osteoporosis Patients
Pfenex, Inc n=181

Data: ClinicalTrials.gov